Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration-Reference-Cited by-同舟云学术

Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration

Published:2018-07-27 Issue:10 Volume:63 Page:1083-1091
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Akiyama Masato,Takahashi Atsushi,Momozawa Yukihide,Arakawa Satoshi,Miya Fuyuki,Tsunoda Tatsuhiko,Ashikawa Kyota,Oshima Yuji,Yasuda Miho,Yoshida Shigeo,Enaida Hiroshi,Tan Xue,Yanagi Yasuo^ORCID,Yasukawa Tsutomu,Ogura Yuichiro,Nagai Yoshimi,Takahashi Kanji,Fujisawa Kimihiko,Inoue Maiko,Arakawa Akira,Tanaka Koji,Yuzawa Mitsuko,Kadonosono Kazuaki,Sonoda Koh-Hei,Ishibashi Tatsuro,Kubo Michiaki

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/s10038-018-0493-0.pdf

Reference30 articles.

1. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728–38.

2. Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921–7.

3. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.

4. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.

5. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209–13.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CFH (rs1061170, rs1410996), KDR (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy;Biomedicines;2024-04-24

2. Pharmacogenetic Association between Allelic Variants of the Autophagy-Related Genes and Anti-Vascular Endothelial Growth Factor Treatment Response in Neovascular Age-Related Macular Degeneration;Biomedicines;2023-11-16

3. Association between Polymorphisms in CFH, ARMS2, CFI, and C3 Genes and Response to Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration;Biomedicines;2022-07-10

4. Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration;International Journal of Molecular Sciences;2022-05-29

5. Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment;Journal of Personalized Medicine;2021-12-08